Literature DB >> 19822787

Stroke incidentally identified using improved positron emission tomography for microglial activation.

William C Kreisl1, Gilbert Mbeo, Masahiro Fujita, Sami S Zoghbi, Victor W Pike, Robert B Innis, Justin C McArthur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822787      PMCID: PMC2762117          DOI: 10.1001/archneurol.2009.208

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  3 in total

1.  PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat.

Authors:  Masao Imaizumi; Hyun-Ju Kim; Sami S Zoghbi; Emmanuelle Briard; Jinsoo Hong; John L Musachio; Christl Ruetzler; De-Maw Chuang; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  Neurosci Lett       Date:  2006-11-28       Impact factor: 3.046

2.  Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors.

Authors:  Masao Imaizumi; Emmanuelle Briard; Sami S Zoghbi; Jonathan P Gourley; Jinsoo Hong; Yota Fujimura; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  Neuroimage       Date:  2007-10-12       Impact factor: 6.556

3.  Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat.

Authors:  D T Stephenson; D A Schober; E B Smalstig; R E Mincy; D R Gehlert; J A Clemens
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

  3 in total
  9 in total

Review 1.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 2.  PET imaging of neuroinflammation in neurological disorders.

Authors:  William C Kreisl; Min-Jeong Kim; Jennifer M Coughlin; Ioline D Henter; David R Owen; Robert B Innis
Journal:  Lancet Neurol       Date:  2020-11       Impact factor: 44.182

3.  Utility of (18) F-FDG and (11)C-PBR28 microPET for the assessment of rat aortic aneurysm inflammation.

Authors:  Sean J English; Jose A Diaz; Xia Shao; David Gordon; Melissa Bevard; Gang Su; Peter K Henke; Virginia E Rogers; Gilbert R Upchurch; Morand Piert
Journal:  EJNMMI Res       Date:  2014-05-10       Impact factor: 3.138

4.  Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain.

Authors:  Rostom Mabrouk; Pablo M Rusjan; Romina Mizrahi; Mark F Jacobs; Yuko Koshimori; Sylvain Houle; Ji Hyun Ko; Antonio P Strafella
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

5.  Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data.

Authors:  Granville J Matheson; Pontus Plavén-Sigray; Anton Forsberg; Andrea Varrone; Lars Farde; Simon Cervenka
Journal:  EJNMMI Res       Date:  2017-07-21       Impact factor: 3.138

6.  Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Authors:  Pontus Plavén-Sigray; Granville James Matheson; Zsolt Cselényi; Aurelija Jucaite; Lars Farde; Simon Cervenka
Journal:  EJNMMI Res       Date:  2018-11-29       Impact factor: 3.138

7.  Neuropathological correlates and genetic architecture of microglial activation in elderly human brain.

Authors:  Daniel Felsky; Tina Roostaei; Kwangsik Nho; Shannon L Risacher; Elizabeth M Bradshaw; Vlad Petyuk; Julie A Schneider; Andrew Saykin; David A Bennett; Philip L De Jager
Journal:  Nat Commun       Date:  2019-01-24       Impact factor: 14.919

8.  positron emission tomography in neuroscience research.

Authors:  N Vanitha
Journal:  Ann Neurosci       Date:  2011-04

Review 9.  In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation.

Authors:  Bastian Zinnhardt; Maximilian Wiesmann; Lisa Honold; Cristina Barca; Michael Schäfers; Amanda J Kiliaan; Andreas H Jacobs
Journal:  Theranostics       Date:  2018-04-03       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.